Form 4: Corcept Therapeutics Director Sells Shares
Insider Transaction (Form 4)
Daniel N Swisher Jr, a Director of Corcept Therapeutics Inc, sold 1,500 shares of common stock on November 10, 2026 for $74.07 per share.
Summary
- Option exercise/conversion: acquired 1,100 Common Stock at $14.08 ($15,488) on November 10, 2026; holds 1,100 after (Direct).
- Option exercise/conversion: acquired 400 Common Stock at $10.50 ($4,200) on November 10, 2026; holds 1,500 after (Direct).
- Open-market sale: disposed of 1,500 Common Stock at $74.07 ($111,105) on November 10, 2026 (Direct).
- Option exercise/conversion: disposed of 1,100 Stock Option (right to buy) on November 10, 2026 (Direct).
- Option exercise/conversion: disposed of 400 Stock Option (right to buy) on November 10, 2026; holds 12,100 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $111,105 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Daniel N Swisher Jr — Director
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-11-10 | Option exercise/conversion | Common Stock | 1,100 | $14 | $15.5K | 1,100 |
| 2026-11-10 | Option exercise/conversion | Common Stock | 400 | $11 | $4.2K | 1,500 |
| 2026-11-10 | Open-market sale | Common Stock | 1,500 | $74 | $111.1K | 0 |
| 2026-11-10 | Option exercise/conversion | Stock Option (right to buy) | 1,100 | — | — | 0 |
| 2026-11-10 | Option exercise/conversion | Stock Option (right to buy) | 400 | — | — | 12,100 |
Key Dates
| Date | Description |
|---|---|
| 2026-11-10 | Option exercise/conversion (1,100 shares) |
| 2026-11-10 | Option exercise/conversion (400 shares) |
| 2026-11-10 | Open-market sale (1,500 shares) |
| 2026-11-10 | Option exercise/conversion (1,100 shares) |
| 2026-11-10 | Option exercise/conversion (400 shares) |
Keywords
insider transaction, Form 4, CORT, CORCEPT THERAPEUTICS INC, bearish, Daniel N Swisher Jr
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.